The Innovation Consortium between Shanghai MOYOM Bio (APHRANEL's Mother Company) and the Chinese Academy of Sciences Was Established

On 18th October 2023, a grand unveiling ceremony was held in Shanghai Qiyate Technology Park. Shanghai Advanced Research Institute, Chinese Academy of Sciences(SARI-CAS) and Shanghai MOYOM Bio-technology Co., Ltd. joined hands to establish an innovation consortium. At the same time, the new building of MOYOM Bio was officially opened. This event marks a solid step forward and a new vitality for MOYOM Bio as a national high-tech enterprise focusing on the research and development, production, sales, and service of biomedical and regenerative materials in the field of women's health, which is committed to promoting the research and development and industrialization of biotechnology.

The innovation consortium between SARI-CAS and Shanghai MOYOM Bio means that the domestic and even the world's top biomedical materials, synthetic biology research and development results, and the translation and application of the natural compound extraction technology will be rapidly transformed in the scientific research platform of MOYOM Bio. Through the strong combination, MOYOM Bio will give full play to its respective advantages, resource sharing, and collaborative innovation, and add bricks and mortar to the progress in the field of biotechnology.

SARI-CAS has a world-class research team and advanced research facilities, and has made outstanding contributions to China's scientific and technological innovation for many years. As an innovative enterprise focusing on nanomedical biomaterials and three resorbable types of implant products, Shanghai MOYOM Bio has rich industrial experience and an excellent R&D technology team. The establishment of this innovation consortium is a seamless connection between scientific research and industry, which will promote the rapid transformation and industrialization of scientific and technological achievements.

The opening of the new MOYOM building

This modern and intelligent building will become an important carrier for MOYOM Bio, carrying the company's exhibition, professional training and education, innovative research and development, high-quality production, and other functions. The opening of the new building will provide a strong guarantee for the rapid development of the company.

Ms. Li Li, Director of Shanghai Minhang District Economic Committee, Mr. Gu Jianping, Deputy Director of Shanghai Minhang District Science and Technology Committee, Mr. Wang Zonghai, Director of Shanghai Industrial Innovation and Incubation Centre, and Mr. Wu Jian, Deputy Secretary General of China Association of Cosmetic Surgery, attended the ribbon-cutting ceremony for the unveiling of the building on the same day. They expressed their warm congratulations on the innovation consortium and hoped that the two organizations would continue to promote R&D and innovation in the field of biotechnology and obtain excellent results.

The innovation consortium between SARI-CAS and Shanghai MOYOM Bio and the opening of the new building are aimed at promoting the transformation of scientific and technological achievements, strengthening the industry chain's collaborative innovation, and contributing to the cause of human health. MOYOM Bio will also combine with the “National Belt and Road”to rapidly promote China's good technology, good products, and good brands to the global mainstream market. MOYOM Bio looks forward to more breakthroughs and surprises from this innovation consortium.